Three additional lots of losartan potassium tablets and two additional lots of losartan potassium/hydrochlorothiazide tablets were under recall, the U.S. Food and Drug Administration said Thursday.

The recalled medications include specific “lots” of losartan, irbesartan, valsartan and combination drugs with valsartan. The investigation is ongoing and the FDA continues to update the list ...

The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. Sandoz Inc. is voluntarily recalling losartan ...

The US Food and Drug Administration says another heart medicine, losartan, is being voluntarily recalled after tests showed that it was tainted with a potential cancer-causing chemical.

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient.

(CNN) -- The recall of popular heart drugs has expanded yet again. This recall includes 30-, 90- and 1,000-count bottles of 100-milligram tablets; 30-, 90- and 1,000-count bottles of 50-milligram ...

The 100-mg/12.5-mg losartan/hydrochlorothiazide formulation will also be manufactured by several other companies, ... You are encouraged to report adverse drug event information to the FDA.

Adverse experiences on losartan/hydrochlorothiazide (43%) ... Antihypertensive treatment in the 1960s and 1970s [13,14,15] generally included initial therapy with multiple drugs.

Patients were randomly assigned to a fixed-dose combination of 50 mg per day losartan and 12.5 mg per day hydrochlorothiazide (HCTZ; n=98), or to a maximal dose of current ARBs (n=95).